Cedar Brook Financial Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,282
| Closed | -$217K | – | 426 |
|
|
2024
Q1 | $217K | Hold |
2,282
| – | – | 0.04% | 404 |
|
|
2023
Q4 | $206K | Buy |
+2,282
| New | +$206K | 0.05% | 390 |
|
|
2022
Q4 | – | Sell |
-4,318
| Closed | -$343K | – | 393 |
|
|
2022
Q3 | $343K | Buy |
4,318
+52
| +1% | +$4.13K | 0.11% | 215 |
|
|
2022
Q2 | $317K | Sell |
4,266
-3,981
| -48% | -$296K | 0.1% | 232 |
|
|
2022
Q1 | $741K | Buy |
8,247
+1,531
| +23% | +$138K | 0.19% | 137 |
|
|
2021
Q4 | $752K | Buy |
+6,716
| New | +$752K | 0.19% | 126 |
|
|
2021
Q1 | – | Sell |
-2,178
| Closed | -$307K | – | 352 |
|
|
2020
Q4 | $307K | Buy |
+2,178
| New | +$307K | 0.11% | 210 |
|